Companies: 10,795·Total market cap: $144.5T
Design Therapeutics, Inc.

Design Therapeutics, Inc.

DSGNNASDAQHealthcare● Active
$10.50
$-0.15(-1.41%)
Market Cap$655760753
P/E Ratio
52W High$17.25
52W Low$3.33
Overview

Design Therapeutics, Inc. (DSGN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · DSGN · as of Mar 9, 2026

Latest filing snapshot

54
+0+0.00%vs prior year

Design Therapeutics, Inc. (DSGN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
54
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
Net Income / Employee
$-1.29M
Market Cap
$658M

DSGN Employee Count

2021 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-0954+0+0.00%
2025-03-1054-4-6.90%
2024-03-1958+0+0.00%
2023-03-1458+20+52.63%
2022-03-1038

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Annexon, Inc.
ANNX
Annexon, Inc.
106
#2
Aura Biosciences, Inc.
AURA
Aura Biosciences, Inc.
106
#3
Altimmune, Inc.
ALT
Altimmune, Inc.
59
#4
enGene Holdings Inc.
ENGN
enGene Holdings Inc.
56
#5
Design Therapeutics, Inc.
DSGN
Design Therapeutics, Inc.YOU
54
#6
DiaMedica Therapeutics Inc.
DMAC
DiaMedica Therapeutics Inc.
27
#7
Galectin Therapeutics Inc.
GALT
Galectin Therapeutics Inc.
15
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · DSGN peer comparison

About DSGN employees

DSGN Employees · Headcount

Design Therapeutics, Inc. (DSGN) employee data is sourced from the annual SEC 10-K filing. As of 2025, Design Therapeutics, Inc. had 54 full-time employees globally. Full-time employees only. Global consolidated headcount.

Design Therapeutics, Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

DSGN Employees · 5 questions

As of the latest SEC 10-K filing (2025), Design Therapeutics, Inc. had 54 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Design Therapeutics, Inc. employee counthow many employees does Design Therapeutics, Inc. haveDSGN total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-09